MANAGEMENT DISCUSSION AND ANALYSIS
INDUSTRY STRUCTURE AND DEVELOPMENTS
The Company is engaged in the manufacturing and selling of drugs intermediates for Pharma, Agriculture, Cosmetics, and Veterinary Industries.
OPPORTUNITIES AND THREATS
Chemical production is heavily reliant on petroleum and natural gas price fluctuations which directly affect profitability. Although we see a good demand for intermediates across different regions, in the chemical sector but fluctuations in crude oil and natural gas prices, key feedstocks for many chemicals, impact resulted in increase in cost of products of the Company and sluggish demand in the market has adversely affected volume of turnover and profit of the Company.
PERFORMANCE
The Companys current business activity has one primary reportable segment, namely Chemicals. The Companys sales for the year 2025-2026 were increased from Rs. 2543.34 Lacs to Rs. 2743.15 Lacs of 2024-2025. The Company has earned a net profit of Rs. 7.69 Lacs in the year 2025-2026 against net loss of Rs. 102.73 Lacs for the year 2024-2025.
OUTLOOK
Your Company has been making consistent efforts to develop new products having good potential demand in the domestic and international market.
RISKS AND CONCERNS
The volatile gulf middle east situation has adversely impacted the performance of the Company in view of increase in raw material price. In addition, the Company has been adhering to the strict compliances of Gujarat Pollution Control Board (GPCB) norms for effective implementation of pollution control measures.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
The Company has in place, commensurate with the size and complexity of Companys business operation, effective internal control systems and policies for compliance of laws and to safeguard the interest of the Company. The internal audit is done by an independent firm of Chartered Accountants. Internal audits are regularly carried out to review the internal control systems. The internal audit reports along with recommendations contained therein are reviewed by the Audit Committee of the Board.
FINANCIAL PERFORMANCE WITH RESPECT TO OPERATIONAL PERFORMANCE
The financial statements of the Company are prepared in accordance with the Indian Accounting Standards (referred to as Ind AS) prescribed under Section 133 of the Companies Act, 2013, read with the Companies (Indian Accounting Standards) Rules, 2015, as amended from time to time. Significant accounting policies used in the preparation of the financial statements are disclosed in the notes to the consolidated financial statements.
The highlights of financial performance of the Company for the year under review are as under:
The Company has earned revenue from operations of Rs. 2743.15 Lacs as compared to net revenue of Rs. 2543.34 Lacs in the previous year and Company has incurred the gross profit of Rs. 13.51 Lacs as compared to gross loss of Rs. 140.25 Lacs in the previous year and net profit of Rs. 7.69 Lacs as compared to net loss of Rs. 102.73 Lacs in the previous year.
DEVELOPMENT IN HUMAN RESOURCE AND INDUSTRIAL RELATION
The Company continues its focus on development of human resources. The Company is a firm believer that its employees are its strength and the Company therefore respects individual rights and dignity of all its employees. The relations of the management with employees during the year continued to be cordial. Learning and development have been strengthened to bring value addition in the employee and to enhance team building leading towards success. The Company focuses on providing the employees, employee - friendly environment and culture and career growth opportunities.
KEY FINANCIAL RATIOS
Details of significant changes (i.e. change of 25% or more as compared to the immediately previous financial year) in key financial ratios, along with detailed explanations thereof:
Financial Ratios |
2025-26 | 2024-25 | Variance |
Trade Receivable Turnover Ratio |
5.33 | 5.00 | 6.51% |
Trade Payables Turnover Ratio |
5.60 | 7.36 | -23.87% |
Inventory Turnover |
2.00 | 2.10 | -4.83% |
Current Ratio |
1.01 | 1.11 | -9.13% |
Debt Equity Ratio (a) |
0.57 | 0.46 | 25.06% |
Debt Service Coverage Ratio (b) |
3.23 | -0.55 | 682.86% |
Net Profit Ratio (%) (f) |
0.28% | -4.04% | 106.94% |
Net Capital turnover Ratio (c) |
45.50 | 31.24 | 45.63% |
Return on Capital Employed (g) |
4.44% | -5.26% | 184.32% |
Return on Equity Ratio (d) |
0.60% | -7.79% | 107.75% |
Return on Investment (e) |
1.78% | 6.28% | -71.63% |
(a) Due to increase of Borrowing
(b) Due to positive Earning
(c) Due to increase of Revenue
(d) Due to positive Earning
(e) No gain on sale of investment during current FY
(f) Due to positive Earning
(g) Due to positive Earning
CAUTIONARY STATEMENT
Statements in this report on describing the Companys objectives, expectations or predictions may be forward looking statements within the meaning of applicable security laws or regulations. These statements are based on certain assumptions and expectations of future events. Actual results could, however, differ materially from those expressed or implied. The Company assumes no responsibility in respect of forward-looking statements herein which may undergo changes in future on the basis of subsequent developments, information or events.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.